Clinical Trials in San Antonio

Showing 2241-2260 of 7,028 trials

FPA150 in Patients With Advanced Solid Tumors

NCT03514121

This is a multi-center study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of FPA150, an anti-B7H4 antibody alone or in combination with pembrolizumab an anti-PD1 antibody in patients with advanced solid tumors. The Phase 1a, open-label, cohort will identify a recommended dose of FPA150 to use for Phase 1a Combination (FPA150 and Pembrolizumab) Safety Lead-in and for Phase 1b monotherapy cohorts.

Breast CancerOvarian CancerEndometrial Cancer+1 more

Five Prime Therapeutics, Inc.95 participantsStarted Mar 2018

Scottsdale, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +15 more locations

COMPLETEDPhase 4< 1 mile

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214

The purpose of this study was to assess the efficacy, safety and tolerability of mirabegron versus placebo in the treatment of older adult subjects with OAB.

Overactive Bladder (OAB)

Astellas Pharma Global Development, Inc.888 participantsStarted Oct 2014

Huntsville, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +117 more locations

FPA150 in Patients With Advanced Solid Tumors

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Find Trials by Condition in San Antonio

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

HIFEM and Radiofrequency for Muscular System Function Improvement

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot